Major Trial Finds MDMA-Assisted Therapy Is Effective for PTSD, Paving Way for FDA Approval
The results of a Phase III trial published this week could soon lead to a new era for the treatment of post-traumatic stress disorder. The study found that a combination of MDMA and psychotherapy was effective at relieving PTSD symptoms when compared to standard therapy. The nonprofit organization funding this research now plans to seek formal approval of MDMA-assisted therapy from the Food and Drug Administration before the end of the year.